| Title: | Investigating the causal relationship between chronic kidney disease and renal cell carcinoma, and establishing a polygenic screening model for identifying high-risk renal cell carcinoma patients |
| Lead Institution: | West China Hospital of Sichuan University |
| Principal investigator: |
Application 105913
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Aims: This research project has two primary objectives: 1) to investigate if chronic kidney disease (CKD) causes renal cell carcinoma (RCC), the most common type of kidney cancer, and 2) to develop a polygenic risk score (PRS) to identify people at high risk for RCC so they can get screened and treated early. Scientific Rationale: CKD affects a lot of people and might raise the risk of getting RCC. But past studies had limitations. We're using a new method (a Mendelian Randomization approach: a scientific method that helps us understand if one thing causes another) to overcome these limitations and to see if CKD really leads to RCC. Additionally, early detection and treatment of RCC are crucial for improving patient outcomes. PRSs, which combine the effect sizes of multiple genetic variants, have shown promise as a tool for risk stratification in various diseases, including cancers. The genetic risk scores we're making can help find high-risk individuals and start treatment sooner. However, it's an area of research that hasn't been explored much. Project Duration: This research project is expected to be completed within 24 months, including data collection, analysis, PRS development and validation, and preparing a report. Public Health Impact: By investigating the causal relationship between CKD and RCC and developing a PRS for RCC risk, this study can give us important insights to the field and ultimately improve patient outcomes. Understanding the relationship between CKD and RCC will help inform potential interventions for patients with CKD, potentially reducing their risk of developing RCC. The development of a PRS for RCC will enable targeted screening and early intervention in those at high risk for RCC, leading to improved survival rates and a reduced burden on healthcare systems. Overall, this project holds significant public interest and value by addressing two critical aspects of RCC management, contributing to better RCC prevention, early detection, and personalized care strategies that benefit public health.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 14344 | Circulating levels of blood biomarkers and risk of benign prostatic hyperplasia: Results from two large cohorts in Europe and East Asia | Shengzhuo Liu (+11) | 2024 | Journal of Global Health |
Enabling scientific discoveries that improve human health